<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34452458</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1593</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13081593</ELocationID><Abstract><AbstractText>Cleavage of double-stranded RNA is described as an evolutionary conserved host defense mechanism against viral infection. Small RNAs are the product and triggers of post transcriptional gene silencing events. Up until now, the relevance of this mechanism for SARS-CoV-2-directed immune responses remains elusive. Herein, we used high throughput sequencing to profile the plasma of active and convalescent COVID-19 patients for the presence of small circulating RNAs. The existence of SARS-CoV-2 derived small RNAs in plasma samples of mild and severe COVID-19 cases is described. Clusters of high siRNA abundance were discovered, homologous to the nsp2 3'-end and nsp4 virus sequence. Four virus-derived small RNA sequences have the size of human miRNAs, and a target search revealed candidate genes associated with ageusia and long COVID symptoms. These virus-derived small RNAs were detectable also after recovery from the disease. The additional analysis of circulating human miRNAs revealed differentially abundant miRNAs, discriminating mild from severe cases. A total of 29 miRNAs were reduced or absent in severe cases. Several of these are associated with JAK-STAT response and cytokine storm.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grehl</LastName><ForeName>Claudius</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulthei&#xdf;</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9789-5776</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV-Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Mascha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV-Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altmann</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Heterosis, OT Gatersleben, 06466 Stadt Seeland, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosse</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5318-4825</Identifier><AffiliationInfo><Affiliation>Institute of Computer Science, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhlmann</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3104-0825</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Heterosis, OT Gatersleben, 06466 Stadt Seeland, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CRC 841</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705667">nsp2 protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073888" MajorTopicYN="N">Cell-Free Nucleic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">circulating-miRNA</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">small RNA</Keyword></KeywordList><CoiStatement>The authors have no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34452458</ArticleId><ArticleId IdType="pmc">PMC8402885</ArticleId><ArticleId IdType="doi">10.3390/v13081593</ArticleId><ArticleId IdType="pii">v13081593</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Felsenstein S., Herbert J., McNamara P.S., Hedrich C.M. COVID-19: Immunology and treatment options. Clin. Immunol. 2020;215:108448. doi: 10.1016/j.clim.2020.108448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108448</ArticleId><ArticleId IdType="pmc">PMC7185015</ArticleId><ArticleId IdType="pubmed">32353634</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosano A., Bella A., Gesualdo F., Acampora A., Pezzotti P., Marchetti S., Ricciardi W., Rizzo C. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14&#x2013;2016/17 seasons) Int. J. Infect. Dis. 2019;88:127&#x2013;134. doi: 10.1016/j.ijid.2019.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.08.003</ArticleId><ArticleId IdType="pubmed">31401203</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster V.J., Koopmans M., van Doremalen N., van Riel D., de Wit E. A novel coronavirus emerging in China&#x2014;Key questions for impact assessment. N. Engl. J. Med. 2020;382:692&#x2013;694. doi: 10.1056/NEJMp2000929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2000929</ArticleId><ArticleId IdType="pubmed">31978293</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift M.A.K., Coupland C.A., Keogh R.H., Hemingway H., Hippisley-Cox J. COVID-19 mortality risk in Down syndrome: Results from a cohort study of 8 million adults. Ann. Intern. Med. 2021;174:572&#x2013;576. doi: 10.7326/M20-4986.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4986</ArticleId><ArticleId IdType="pmc">PMC7592804</ArticleId><ArticleId IdType="pubmed">33085509</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B.R. RNA interference: Antiviral defense and genetic tool. Nat. Immunol. 2002;3:597&#x2013;599. doi: 10.1038/ni0702-597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0702-597</ArticleId><ArticleId IdType="pubmed">12087412</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabalina S.A., Koonin E.V. Origins and evolution of eukaryotic RNA interference. Trends Ecol. Evol. 2008;23:578&#x2013;587. doi: 10.1016/j.tree.2008.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tree.2008.06.005</ArticleId><ArticleId IdType="pmc">PMC2695246</ArticleId><ArticleId IdType="pubmed">18715673</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundhoff A., Sullivan C.S. Virus-encoded microRNAs. Virology. 2011;411:325&#x2013;343. doi: 10.1016/j.virol.2011.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.01.002</ArticleId><ArticleId IdType="pmc">PMC3052296</ArticleId><ArticleId IdType="pubmed">21277611</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X., Hackbart M., Mettelman R., O&#x2019;Brien A., Mielech A.M., Yi G., Kao C.C., Baker S.C. Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages. Proc. Natl. Acad. Sci. USA. 2017;114:E4251&#x2013;E4260. doi: 10.1073/pnas.1618310114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1618310114</ArticleId><ArticleId IdType="pmc">PMC5448190</ArticleId><ArticleId IdType="pubmed">28484023</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeang K.-T. RNAi in the regulation of mammalian viral infections. BMC Biol. 2012;10:58. doi: 10.1186/1741-7007-10-58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7007-10-58</ArticleId><ArticleId IdType="pmc">PMC3383472</ArticleId><ArticleId IdType="pubmed">22734679</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B.-J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.-J., Woodle M.C., et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 2005;11:944&#x2013;951. doi: 10.1038/nm1280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1280</ArticleId><ArticleId IdType="pmc">PMC7095788</ArticleId><ArticleId IdType="pubmed">16116432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Cao Y.-L., Yang F., Zhang Y., Wang S.-H., Liu L. Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites. Molecules. 2010;15:7197&#x2013;7207. doi: 10.3390/molecules15107197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules15107197</ArticleId><ArticleId IdType="pmc">PMC6259191</ArticleId><ArticleId IdType="pubmed">20956884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Yuan Y., Cho J.-H., McClarty S., Baxter D., Galas D.J. Comparing the microRNA spectrum between serum and plasma. PLoS ONE. 2012;7:e41561. doi: 10.1371/journal.pone.0041561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041561</ArticleId><ArticleId IdType="pmc">PMC3409228</ArticleId><ArticleId IdType="pubmed">22859996</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z., Wang J., Wang Z., Sun Y., Wu J., Zhang Y., Liu X., Zhou Z., Zhou L., Zhang C.Y., et al. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov. 2021;7:48. doi: 10.1038/s41421-021-00289-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00289-8</ArticleId><ArticleId IdType="pmc">PMC8257610</ArticleId><ArticleId IdType="pubmed">34226530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong X., Jia L., Hong L., Pan L., Xue X., Zhang C., Lu J., Jin Z., Qiu H., Wu R., et al. Serum miR-92a-3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions. J. Cardiovasc. Transl. Res. 2016;10:1&#x2013;8. doi: 10.1007/s12265-016-9717-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-016-9717-x</ArticleId><ArticleId IdType="pubmed">27981487</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijsen A.J., Pinto Y.M., Creemers E.E. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol. 2012;303:H1085&#x2013;H1095. doi: 10.1152/ajpheart.00191.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00191.2012</ArticleId><ArticleId IdType="pubmed">22942181</ArticleId></ArticleIdList></Reference><Reference><Citation>Geekiyanage H., Rayatpisheh S., Wohlschlegel J.A., Brown R., Ambros V. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc. Natl. Acad. Sci. USA. 2020;117:24213&#x2013;24223. doi: 10.1073/pnas.2008323117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008323117</ArticleId><ArticleId IdType="pmc">PMC7533700</ArticleId><ArticleId IdType="pubmed">32929008</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy P.M., Bhakta N.R., Barczak A.J., Cakmak H., Fisher S., MacKenzie T.C., Patel T., Price R.W., Smith J.F., Woodruff P.G., et al. Large differences in small RNA composition between human biofluids. Cell Rep. 2018;25:1346&#x2013;1358. doi: 10.1016/j.celrep.2018.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.10.014</ArticleId><ArticleId IdType="pmc">PMC6261476</ArticleId><ArticleId IdType="pubmed">30380423</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102433</ArticleId><ArticleId IdType="pmc">PMC7127067</ArticleId><ArticleId IdType="pubmed">32113704</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson E.I., Prince T., Anderson E.R., Casas-Sanchez A., Smith S.L., Cansado-Utrilla C., Solomon T., Griffiths M.J., Acosta-Serrano A., Turtle L., et al. Methods of inactivation of SARS-CoV-2 for downstream biological assays. J. Infect. Dis. 2020;222:1462&#x2013;1467. doi: 10.1093/infdis/jiaa507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa507</ArticleId><ArticleId IdType="pmc">PMC7529010</ArticleId><ArticleId IdType="pubmed">32798217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipps C., Northe P., Figueiredo R., Rohde M., Brahmer A., Kr&#xe4;mer-Albers E.-M., Liebetrau C., Wiedenroth C.B., Mayer E., Kriechbaum S.D., et al. Non-invasive approach for evaluation of pulmonary hypertension using extracellular vesicle-associated small non-coding RNA. Biomolecules. 2019;9:666. doi: 10.3390/biom9110666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9110666</ArticleId><ArticleId IdType="pmc">PMC6920761</ArticleId><ArticleId IdType="pubmed">31671920</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Paschold L., Simnica D., Mohme M., Willscher E., von Wenserski L., Scholz R., Wieters I., Dahlke C., Tolosa E., et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53:442&#x2013;455.e4. doi: 10.1016/j.immuni.2020.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.024</ArticleId><ArticleId IdType="pmc">PMC7324317</ArticleId><ArticleId IdType="pubmed">32668194</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu A., Zhu H., Gao B., Weng H., Ding Z., Li M., Weng X., He G. Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: A case report. BMC Infect. Dis. 2020;20:45. doi: 10.1186/s12879-019-4733-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4733-5</ArticleId><ArticleId IdType="pmc">PMC6964051</ArticleId><ArticleId IdType="pubmed">31941459</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Z., Du R., Edwards A., Flemington E.K., Zhang K. The sequence structures of human microRNA molecules and their implications. PLoS ONE. 2013;8:e54215. doi: 10.1371/journal.pone.0054215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054215</ArticleId><ArticleId IdType="pmc">PMC3548844</ArticleId><ArticleId IdType="pubmed">23349828</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X., Zhuang Z., Zhao P.X. psRNATarget: A plant small RNA target analysis server (2017 release) Nucleic Acids Res. 2018;46:W49&#x2013;W54. doi: 10.1093/nar/gky316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky316</ArticleId><ArticleId IdType="pmc">PMC6030838</ArticleId><ArticleId IdType="pubmed">29718424</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Taste perception: From the tongue to the testis. Mol. Hum. Reprod. 2013;19:349&#x2013;360. doi: 10.1093/molehr/gat009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/gat009</ArticleId><ArticleId IdType="pubmed">23423265</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks C., Belluscio L., Ib&#xe1;&#xf1;ez C.F. Critical role of GFR1 in the development and function of the main olfactory system. J. Neurosci. 2012;32:17306&#x2013;17320. doi: 10.1523/JNEUROSCI.1522-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1522-12.2012</ArticleId><ArticleId IdType="pmc">PMC3655334</ArticleId><ArticleId IdType="pubmed">23197722</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y.C., O&#x2019;Connell J.R., Cole J.W., Stine O.C., Dueker N., McArdle P.F., Sparks M.J., Shen J., Laurie C.C., Nelson S., et al. Genome-wide association analysis of ischemic stroke in young adults. G3 Genes Genomes Genet. 2011;1:505&#x2013;514. doi: 10.1534/g3.111.001164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.111.001164</ArticleId><ArticleId IdType="pmc">PMC3276159</ArticleId><ArticleId IdType="pubmed">22384361</ArticleId></ArticleIdList></Reference><Reference><Citation>Piatto V.B., De Carvalho T.B.O., De Marchi N.S.A., Molina F.D., Maniglia J.V. Polymorphisms in the 5-HTR2A gene related to obstructive sleep apnea syndrome. Braz. J. Otorhinolaryngol. 2011;77:348&#x2013;355. doi: 10.1590/S1808-86942011000300013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1808-86942011000300013</ArticleId><ArticleId IdType="pmc">PMC9444524</ArticleId><ArticleId IdType="pubmed">21739010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T., Staines D., Nilius B., Smith P., Marshall-Gradisnik S. Novel identification and characterisation of transient receptor potential melastatin 3 ion channels on natural killer cells and B lymphocytes: Effects on cell signalling in chronic fatigue syndrome/myalgic encephalomyelitis patients. Biol. Res. 2016;49:1&#x2013;8. doi: 10.1186/s40659-016-0087-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-016-0087-2</ArticleId><ArticleId IdType="pmc">PMC4888729</ArticleId><ArticleId IdType="pubmed">27245705</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S., Giani T., Tascini C. Intussusceptive angiogenesis in Covid-19: Hypothesis on the significance and focus on the possible role of FGF2. Mol. Biol. Rep. 2020;47:8301&#x2013;8304. doi: 10.1007/s11033-020-05831-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-020-05831-7</ArticleId><ArticleId IdType="pmc">PMC7486971</ArticleId><ArticleId IdType="pubmed">32920756</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja D.M., Philippe A., Bory O., Gendron N., Beauvais A., Gruest M., Peron N., Khider L., Guerin C.L., Goudot G., et al. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J. Thromb. Haemost. 2021;19:1823&#x2013;1830. doi: 10.1111/jth.15339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15339</ArticleId><ArticleId IdType="pmc">PMC8250221</ArticleId><ArticleId IdType="pubmed">33830623</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong R.-K., Seo S.-W., Kim J.-A., Fletcher S.J., Morgan N., Kumar M., Choi Y.-K., Shin O.S. Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication. Immunobiology. 2017;222:979&#x2013;988. doi: 10.1016/j.imbio.2017.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2017.07.002</ArticleId><ArticleId IdType="pmc">PMC5990420</ArticleId><ArticleId IdType="pubmed">28734654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozomara A., Birgaoanu M., Griffiths-Jones S. miRBase: From microRNA sequences to function. Nucleic Acids Res. 2018;47:D155&#x2013;D162. doi: 10.1093/nar/gky1141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1141</ArticleId><ArticleId IdType="pmc">PMC6323917</ArticleId><ArticleId IdType="pubmed">30423142</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Fan J., Zhao Y., Zhang X., Dai B., Zhan J., Yin Z., Nie X., Fu X.-D., Chen C., et al. Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart. Circ. Res. 2019;125:1106&#x2013;1120. doi: 10.1161/CIRCRESAHA.119.314898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.314898</ArticleId><ArticleId IdType="pmc">PMC6903355</ArticleId><ArticleId IdType="pubmed">31638474</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Li X. Downregulation of miR-320 alleviates endoplasmic reticulum stress and inflammatory response in 3T3-L1 adipocytes. Exp. Clin. Endocrinol. Diabetes. 2019;129:131&#x2013;137. doi: 10.1055/a-1012-8420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1012-8420</ArticleId><ArticleId IdType="pubmed">31634961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Z.-Q., Jiang H., Lu Z.-B. MiR-320 regulates cardiomyocyte apoptosis induced by ischemia&#x2013;reperfusion injury by targeting AKIP1. Cell. Mol. Biol. Lett. 2018;23:41. doi: 10.1186/s11658-018-0105-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-018-0105-1</ArticleId><ArticleId IdType="pmc">PMC6114048</ArticleId><ArticleId IdType="pubmed">30181740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndzi E.N., Nkenfou C.N., Mekue L.M., Zentilin L., Tamgue O., Pefura E.W.Y., Kuiate J.R., Giacca M., Ndjolo A. MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis. Tuberculosis. 2019;114:69&#x2013;76. doi: 10.1016/j.tube.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2018.12.001</ArticleId><ArticleId IdType="pubmed">30711160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschner M.B., Cheng Y.Y., Badrian B., Kao S.C., Creaney J., Edelman J.J.B., Armstrong N.J., Vallely M.P., Musk A.W., Robinson B.W., et al. Increased Circulating miR-625-3p: A potential biomarker for patients with malignant pleural mesothelioma. J. Thorac. Oncol. 2012;7:1184&#x2013;1191. doi: 10.1097/JTO.0b013e3182572e83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e3182572e83</ArticleId><ArticleId IdType="pubmed">22617246</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S.A., Jhun B.W., Kim S.-Y., Moon S.M., Yang B., Kwon O.J., Daley C.L., Shin S.J., Koh W.-J. miRNA expression profiles and potential as biomarkers in nontuberculous mycobacterial pulmonary disease. Sci. Rep. 2020;10:3178. doi: 10.1038/s41598-020-60132-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60132-0</ArticleId><ArticleId IdType="pmc">PMC7035291</ArticleId><ArticleId IdType="pubmed">32081976</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian F.-H., Deng X., Zhuang Q.-X., Wei B., Zheng D.-D. miR-625-5p suppresses inflammatory responses by targeting AKT2 in human bronchial epithelial cells. Mol. Med. Rep. 2019;19:1951&#x2013;1957. doi: 10.3892/mmr.2019.9817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.9817</ArticleId><ArticleId IdType="pubmed">30628701</ArticleId></ArticleIdList></Reference><Reference><Citation>Graier T., Golob-Schwarzl N., Weger W., Benezeder T., Painsi C., Salmhofer W., Wolf P. Furin expression in patients with psoriasis&#x2014;A patient cohort endangered to SARS-COV2? Front. Med. 2021;8:624462. doi: 10.3389/fmed.2021.624462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.624462</ArticleId><ArticleId IdType="pmc">PMC7902756</ArticleId><ArticleId IdType="pubmed">33644099</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejad C., Stunden H.J., Gantier M.P. A guide to miRNAs in inflammation and innate immune responses. FEBS J. 2018;285:3695&#x2013;3716. doi: 10.1111/febs.14482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14482</ArticleId><ArticleId IdType="pubmed">29688631</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam T., Lipovich L. miRCOVID-19: Potential targets of human miRNAs in SARS-CoV-2 for RNA-based drug discovery. Noncoding RNA. 2021;7:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005926</ArticleId><ArticleId IdType="pubmed">33801496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-M., Gong Y.-N., Shih S.-R. Methods for detection and study of virus-derived small RNAs produced from the intramolecular base-pairing region of the picornavirus genome. Methods. 2019;183:4&#x2013;12. doi: 10.1016/j.ymeth.2019.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2019.08.011</ArticleId><ArticleId IdType="pubmed">31493516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K., Courtney D.G., Kennedy E.M., Cullen B.R. Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replication. RNA. 2018;24:1172&#x2013;1182. doi: 10.1261/rna.066332.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.066332.118</ArticleId><ArticleId IdType="pmc">PMC6097656</ArticleId><ArticleId IdType="pubmed">29903832</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster S., Overheul G., Bauer L., Van Kuppeveld F.J.M., Van Rij R.P. No evidence for viral small RNA production and antiviral function of Argonaute 2 in human cells. Sci. Rep. 2019;9:13752. doi: 10.1038/s41598-019-50287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-50287-w</ArticleId><ArticleId IdType="pmc">PMC6760161</ArticleId><ArticleId IdType="pubmed">31551491</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino G.A., Raad J., Bugnon L.A., Yones C., Kamenetzky L., Claus J., Ariel F., Milone D.H., Stegmayer G. Novel SARS-CoV-2 encoded small RNAs in the passage to humans. Bioinformatics. 2021;36:5571&#x2013;5581. doi: 10.1093/bioinformatics/btaa1002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa1002</ArticleId><ArticleId IdType="pmc">PMC7717134</ArticleId><ArticleId IdType="pubmed">33244583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincaid R.P., Burke J.M., Sullivan C.S. RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. USA. 2012;109:3077&#x2013;3082. doi: 10.1073/pnas.1116107109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1116107109</ArticleId><ArticleId IdType="pmc">PMC3286953</ArticleId><ArticleId IdType="pubmed">22308400</ArticleId></ArticleIdList></Reference><Reference><Citation>Duy J., Honko A.N., Altamura L.A., Bixler S.L., Wollen-Roberts S., Wauquier N., O&#x2019;Hearn A., Mucker E.M., Johnson J.C., Shamblin J.D., et al. Virus-encoded miRNAs in Ebola virus disease. Sci. Rep. 2018;8:6480. doi: 10.1038/s41598-018-23916-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23916-z</ArticleId><ArticleId IdType="pmc">PMC5915558</ArticleId><ArticleId IdType="pubmed">29691416</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x201c;long COVID&#x201d;: Rationale, physiology and management strategies. Clin. Med. 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., Sagulenko P., Bedford T., Neher R.A. Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121&#x2013;4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Varkonyi-Gasic E., Wu R., Wood M., Walton E.F., Hellens R.P. Protocol: A highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods. 2007;3:12. doi: 10.1186/1746-4811-3-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1746-4811-3-12</ArticleId><ArticleId IdType="pmc">PMC2225395</ArticleId><ArticleId IdType="pubmed">17931426</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.L., Hoang V.T., Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: A narrative review. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:13&#x2013;25. doi: 10.1007/s10096-020-04088-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04088-z</ArticleId><ArticleId IdType="pmc">PMC7592450</ArticleId><ArticleId IdType="pubmed">33113040</ArticleId></ArticleIdList></Reference><Reference><Citation>Roltgen K., Wirz O.F., Stevens B.A., Powell A.E., Hogan C.A., Najeeb J., Hunter M., Sahoo M.K., Huang C., Yamamoto F., et al. SARS-CoV-2 antibody responses correlate with resolution of RNAemia but are short-lived in patients with mild illness. medRxiv. 2020 doi: 10.1101/2020.08.15.20175794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.15.20175794</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Jiang M., Wang X., Tang X., Fang S., Li H., Zuo L., Jiang Y., Zhong Y., Chen Q., et al. Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: A population-based observational cohort study. Emerg. Microbes Infect. 2020;9:2368&#x2013;2378. doi: 10.1080/22221751.2020.1837018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1837018</ArticleId><ArticleId IdType="pmc">PMC7655076</ArticleId><ArticleId IdType="pubmed">33151135</ArticleId></ArticleIdList></Reference><Reference><Citation>Azghandi M., Kerachian M.A. Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens. J. Transl. Med. 2020;18:412. doi: 10.1186/s12967-020-02589-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02589-1</ArticleId><ArticleId IdType="pmc">PMC7605324</ArticleId><ArticleId IdType="pubmed">33138836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-Y., Lu R.-B., Wang L.-J., Chang C.-H., Lu T., Wang T.-Y., Tsai K.-W. Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder. Sci. Rep. 2020;10:1131. doi: 10.1038/s41598-020-58195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58195-0</ArticleId><ArticleId IdType="pmc">PMC6981268</ArticleId><ArticleId IdType="pubmed">31980721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y., Zhao K., Qi Y., Min X., Shi Z., Qi X., Shan Y., Cui L., Zhou M., Wang Y., et al. Serum microRNA expression profile as a biomarker for the diagnosis of pertussis. Mol. Biol. Rep. 2012;40:1325&#x2013;1332. doi: 10.1007/s11033-012-2176-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-012-2176-9</ArticleId><ArticleId IdType="pubmed">23073777</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A., Leidinger P., Vogel B., Backes C., El Sharawy A., Galata V., Mueller S.C., Marquart S., Schrauder M.G., Strick R., et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014;12:224. doi: 10.1186/s12916-014-0224-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0224-0</ArticleId><ArticleId IdType="pmc">PMC4268797</ArticleId><ArticleId IdType="pubmed">25465851</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Noroozi R., Branicki W., Pyrc K., Labaj P.P., Pospiech E., Taheri M., Ghafouri-Fard S. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. Cytokine. 2020;133:155143. doi: 10.1016/j.cyto.2020.155143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155143</ArticleId><ArticleId IdType="pmc">PMC7241386</ArticleId><ArticleId IdType="pubmed">32460144</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay D., Mussa B.M. Identification of novel hypothalamic microRNAs as promising therapeutics for SARS-CoV-2 by regulating ACE2 and TMPRSS2 expression: An in silico analysis. Brain Sci. 2020;10:666. doi: 10.3390/brainsci10100666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10100666</ArticleId><ArticleId IdType="pmc">PMC7601472</ArticleId><ArticleId IdType="pubmed">32992681</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Gao Y., Li Z., Miao Y., Huang Z., Liu X., Xie L., Li H., Wen W., Zheng Y., et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med. 2020;10:e200. doi: 10.1002/ctm2.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X.X., Yu R., Wu X., Wu S.Y., Pi C., Chen Z.H., Zhang X.C., Gao C.Y., Shao Y.W., Liu L., et al. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer. J. Immunother. Cancer. 2020;8:e000376. doi: 10.1136/jitc-2019-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2019-000376</ArticleId><ArticleId IdType="pmc">PMC7057418</ArticleId><ArticleId IdType="pubmed">31959728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Chen M., Tellgren-Roth C., Pettersson U. Fluctuating expression of microRNAs in adenovirus infected cells. Virology. 2015;478:99&#x2013;111. doi: 10.1016/j.virol.2015.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.01.033</ArticleId><ArticleId IdType="pubmed">25744056</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller A., Ludwig N., Fehlmann T., Kahraman M., Backes C., Kern F., Vogelmeier C.F., Diener C., Fischer U., Biertz F., et al. Low miR-150-5p and miR-320b expression predicts reduced survival of COPD patients. Cells. 2019;8:1162. doi: 10.3390/cells8101162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101162</ArticleId><ArticleId IdType="pmc">PMC6848926</ArticleId><ArticleId IdType="pubmed">31569706</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Gong Y., Ma J., Gong X. Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502-3p/OLFM4/STAT3 pathway. Biomed. Pharmacother. 2020;127:110219. doi: 10.1016/j.biopha.2020.110219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110219</ArticleId><ArticleId IdType="pubmed">32559850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai R., Yang Q., Xi R., Li L., Shi D., Chen K. miR-941 as a promising biomarker for acute coronary syndrome. BMC Cardiovasc. Disord. 2017;17:227. doi: 10.1186/s12872-017-0653-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-017-0653-8</ArticleId><ArticleId IdType="pmc">PMC5568367</ArticleId><ArticleId IdType="pubmed">28830367</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Seeliger B., Derda A.A., Xiao K., Gietz A., Scherf K., Sonnenschein K., Pink I., Hoeper M.M., Welte T., et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 2021;23:468&#x2013;475. doi: 10.1002/ejhf.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschalaki K.E., Zampetaki A., Baker J.R., Birrell M.A., Starke R.D., Belvisi M.G., Donnelly L.E., Mayr M., Randi A.M., Barnes P.J. Downregulation of microRNA-126 augments DNA damage response in cigarette smokers and patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2018;197:665&#x2013;668. doi: 10.1164/rccm.201706-1304LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201706-1304LE</ArticleId><ArticleId IdType="pmc">PMC6005241</ArticleId><ArticleId IdType="pubmed">28753388</ArticleId></ArticleIdList></Reference><Reference><Citation>Arend D., Lange M., Chen J., Colmsee C., Flemming S., Hecht D., Scholz U. e! DAL&#x2014;A framework to store, share and publish research data. BMC Bioinform. 2014;15:214. doi: 10.1186/1471-2105-15-214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-214</ArticleId><ArticleId IdType="pmc">PMC4080583</ArticleId><ArticleId IdType="pubmed">24958009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>